Syngene International Limited
An Associate Director in Invitro ADME at Syngene leads a high-performing team of scientists to design, execute, and interpret complex in-vitro drug metabolism studies that influence molecule progression decisions. The role involves owning scientific strategy, ensuring operational excellence, and driving automation initiatives within a dynamic drug discovery environment while maintaining strict safety and quality standards.
We are an innovation-led contract research, development and manufacturing organization offering end-to-end solutions to fulfil R&D and manufacturing requirements of our clients
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Syngene International Limited.
Syngene International Limited didn’t post a salary, so this is our estimate from similar listings.
13% below the average for this role
Senior Scientist - ADME
Massachusetts General Hospital
Principal Scientist: PKDM-BA (Small molecule in vitro ADME group lead)
Amgen
Principal Scientist - ADME - Site Based, Princeton, NJ
Evotec
Senior Research Associate - In Vitro ADME
Crown Bioscience, Inc.
Associate Director, Discovery DMPK – In Vitro ADME
pharmaron
Senior Scientist, High-Throughput In Vitro ADME
BioLife Plasma Services